Given the current underperformance of European banks and the downsizing of IBDs (e.g. DB, Barclays), how is advisory (M&A and equity/ debt underwriting) going to develop in the future?
Are independent advisors taking over?
(This applies in particular to European banks)
| +219 | UBS Accused of Favoring H-1B Workers While Cutting U.S.-Born Employees | 51 | 18h |
| +111 | ONLY THESE BANKS OR YOU STRUCK OUT | 33 | 2h |
| +109 | IB Energy Drink Tier List / Ranking | 72 | 1d |
| +91 | PJT M&A Group Selection 2026 | 14 | 22h |
| +54 | Firm Thinks I'm Lying About Offer | 18 | 15h |
| +51 | Feedback for internship first desk at IBD BB - personal fit, "don't be too confident" | 29 | 1d |
| +31 | Stay at Weak Dealflow Team or Lateral? | 10 | 30m |
| +30 | Does BofA still pay its associates rat pellets? | 15 | 1d |
| +28 | Indiana University Fraternity Pipelines | 14 | 1h |
| +27 | Rogo AI | 6 | 11h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Personally I think industry wise I think definitely EBs (+ european boutiques like Robey Warshaw) + US BB will take over more market share that DB/UBS lose.
Not sure how specific firms will do but if I had to guess DB will always have a presence (german pride + solid historic performance) in EMEA especially with European lev fin although with the piss poor balance sheet I think it'll take at least 2-3 more years of restructuring before they think about any growth. CS is still a strong player in IB esp EMEA and the CEO just said they won't be downsizing anymore (albeit I believe he was referring to S&T more so). I think Barclays wants to continue its investment into IB and grow the group, have seen couple of hires within Chemicals/Industrials/HC in the US so I'd reckon they'd be continuing that for Europe (not sure which groups in particular though just making a guess). UBS I have no idea with all the focus on PWM/AM I'm surprised they're still decently strong with IB.
I think couple 3rd tier firms like BNP/Soc Gen/HSBC will be interesting. I think in the next couple of years some will completely be even more irrelevant (Soc Gen) whereas others (HSBC) have a chance maybe to gain a bit more market share.
Just my opinion based on what I'm hearing from buddies of mine in different firms and reading the news. Then again based in the US so I could be 100% wrong.
Quaerat autem voluptas sint recusandae modi. Beatae aliquam ullam soluta et. Dolorum tempore qui omnis beatae quis non quam. Facilis enim consequatur a. Ipsum voluptatem libero laboriosam esse.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...